1067645

Hikma Pharmaceuticals USA Inc. — FEI 2220525

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 14, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cherry Hill, NJ (United States)